Morning Overview on MSN

An SGLT2 pill protected the kidneys of teenagers with type 1 diabetes in a new trial

Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...
Morning Overview on MSN

A new wearable tracks both blood sugar and ketones from a single sensor

People with diabetes who need to track both glucose and ketone levels have long juggled separate devices, pricking their ...
Medical Dialogues

Study Finds One-Third of ED Patients Diagnosed With DKA Despite Not Meeting Laboratory Criteria

The researchers concluded that emergency physicians often diagnose DKA despite the absence of initial laboratory criteria, ...
The Lancet

Fluids in paediatric diabetic ketoacidosis: the choice is not solely academic

bPediatric Diabetes Unit, Department of Pediatrics, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy cDepartment of Women's and ...
ahajournals.org

Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis

SGLT2 (sodium-glucose cotransporter 2) inhibitors produce a distinctive pattern of benefits on the evolution and progression of cardiomyopathy and nephropathy, which is characterized by a reduction in ...